SYF
71
7
WFC
55
5
ITW
43
6
EBAY
47
-2
PNR
56
6
LH
45
2
CCL
54
4
XEL
44
5
FLR
48
2
QCOM
53
2
RHI
44
4
CSX
36
3
MCK
56
4
CAH
50
2
L
49
4
AEE
64
3
SWKS
48
2
BRK.B
22
7
MDT
73
9
CNX
48
2
SYF
71
7
WFC
55
5
ITW
43
6
EBAY
47
-2
PNR
56
6
LH
45
2
CCL
54
4
XEL
44
5
FLR
48
2
QCOM
53
2
RHI
44
4
CSX
36
3
MCK
56
4
CAH
50
2
L
49
4
AEE
64
3
SWKS
48
2
BRK.B
22
7
MDT
73
9
CNX
48
2
Financhill
Back

IQVIA Holdings Vs. Blueprint Medicines Industry Stock Comparison

Sell
9

IQV
IQVIA Holdings

Last Price:
$198.04
Seasonality Move:
3.75%
Sell
40

BPMC
Blueprint Medicines

Last Price:
$102.47
Seasonality Move:
5.27%
Sell
9
IQVIA Holdings (IQV) is a Sell

Is IQVIA Holdings a Buy, Sell or Hold?

  • The current IQVIA Holdings [IQV] share price is $197.96. The Score for IQV is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • IQV is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
40
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $102.56. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IQV Stock Price Chart

What is IQVIA Holdings's stock price today?

  • The IQVIA Holdings share price today is $197.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IQV is experiencing slight selling pressure.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $102.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing selling pressure, which indicates risk of future bearish movement.

IQV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 45.45 Sell
Chaikin Money Flow: -978011 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (195.63 - 203.05) Sell
Bollinger Bands (100): (200.04 - 238.16) Sell

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.85 Buy
Relative Strength Index (14 RSI): 63.82 Buy
Chaikin Money Flow: -913925 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.06 - 96.6) Buy
Bollinger Bands (100): (86.99 - 95.95) Buy

IQV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 200.58 Sell
20-day SMA: 198.49 Sell
50-day SMA: 202.13 Sell
200-day SMA: 223.96 Sell
8-day EMA: 200.81 Sell
20-day EMA: 200.18 Sell
50-day EMA: 204.69 Sell
200-day EMA: 218.47 Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.93 Buy
20-day SMA: 91.76 Buy
50-day SMA: 93.83 Buy
200-day SMA: 96.87 Buy
8-day EMA: 94.89 Buy
20-day EMA: 92.92 Buy
50-day EMA: 92.72 Buy
200-day EMA: 91.71 Buy

IQVIA Holdings Earnings Growth & IQV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.82 per share, and an increase next year of $1.38 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.

IQVIA Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):